TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 31 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $65,000 | -26.1% | 13,236 | 0.0% | 0.00% | – |
| Q3 2016 | $88,000 | +51.7% | 13,236 | 0.0% | 0.00% | – |
| Q2 2016 | $58,000 | -37.6% | 13,236 | 0.0% | 0.00% | – |
| Q1 2016 | $93,000 | -23.8% | 13,236 | 0.0% | 0.00% | – |
| Q4 2015 | $122,000 | +114.0% | 13,236 | +126.5% | 0.00% | – |
| Q3 2015 | $57,000 | – | 5,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 1,889,652 | $26,531,000 | 1.20% |
| WALL STREET ASSOCIATES | 250,000 | $3,510,000 | 0.33% |
| QVT Financial LP | 368,330 | $5,001,000 | 0.28% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 485,000 | $6,809,000 | 0.22% |
| Perceptive Advisors | 100,000 | $1,404,000 | 0.11% |
| Visium Asset Management, LP | 461,336 | $6,477,000 | 0.10% |
| Opaleye Management Inc. | 12,172 | $171,000 | 0.08% |
| Candriam S.C.A. | 125,000 | $1,755,000 | 0.04% |
| Spark Investment Management LLC | 13,300 | $186,000 | 0.03% |
| Nicholas Investment Partners, LP | 30,000 | $421,000 | 0.03% |